Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium
暂无分享,去创建一个
[1] F. Marques,et al. How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure , 2022, Current Hypertension Reports.
[2] Duo-duo Ren,et al. Panax quinquefolius Polysaccharides Ameliorate Antibiotic-Associated Diarrhoea Induced by Lincomycin Hydrochloride in Rats via the MAPK Signaling Pathways , 2022, Journal of immunology research.
[3] R. Ashour,et al. Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression. , 2022, International immunopharmacology.
[4] Yinshi Sun,et al. The Protective Effects of Ginseng Polysaccharides and Their Effective Subfraction against Dextran Sodium Sulfate-Induced Colitis , 2022, Foods.
[5] Dake Cai,et al. Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis. , 2021, Pharmacological research.
[6] Chengjie Guo,et al. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. , 2021, Carbohydrate polymers.
[7] Xiuqi Zhang,et al. Crataegus pinnatifida polysaccharide alleviates colitis via modulation of gut microbiota and SCFAs metabolism. , 2021, International journal of biological macromolecules.
[8] Le Zhang,et al. Dietary Taxifolin Protects Against Dextran Sulfate Sodium-Induced Colitis via NF-κB Signaling, Enhancing Intestinal Barrier and Modulating Gut Microbiota , 2021, Frontiers in Immunology.
[9] Daqing Zhao,et al. Recent progress in polysaccharides from Panax ginseng C. A. Meyer. , 2020, Food & function.
[10] Yiqing Ye,et al. The role of short-chain fatty acids in immunity, inflammation and metabolism , 2020, Critical reviews in food science and nutrition.
[11] Jie Song,et al. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. , 2020, International journal of biological macromolecules.
[12] C. K. Yao,et al. Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] A. Farone,et al. Panax quinquefolius (North American ginseng) cell suspension culture as a source of bioactive polysaccharides: Immunostimulatory activity and characterization of a neutral polysaccharide AGC1. , 2019, International journal of biological macromolecules.
[14] K. Faber,et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..
[15] Jana G Hashash,et al. A comprehensive review and update on ulcerative colitis. , 2019, Disease-a-month : DM.
[16] D. Sohn,et al. Ameliorative effect of Alnus japonica ethanol extract on colitis through the inhibition of inflammatory responses and attenuation of intestinal barrier disruption in vivo and in vitro. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[17] Ying Xie,et al. Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota , 2018, Pharmacological research.
[18] Tiehua Zhang,et al. Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides , 2018, Nutrients.
[19] K. Takeda,et al. Maintenance of intestinal homeostasis by mucosal barriers , 2018, Inflammation and regeneration.
[20] K. Takeda,et al. Maintenance of intestinal homeostasis by mucosal barriers , 2018, Inflammation and Regeneration.
[21] S. Batra,et al. Mouse Model of Dextran Sodium Sulfate (DSS)-induced Colitis. , 2017, Bio-protocol.
[22] D. Kalman,et al. Layered defense: how mucus and tight junctions seal the intestinal barrier , 2017, Journal of Molecular Medicine.
[23] L. Peyrin-Biroulet,et al. Ulcerative colitis , 2017, The Lancet.
[24] Richard Hodson. Inflammatory bowel disease , 2016, Nature.
[25] W. Garrett,et al. Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.
[26] T. Meštrović,et al. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients , 2016, International journal of molecular sciences.
[27] R. D'Incà,et al. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.
[28] L. Menchen,et al. A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[29] Hiroshi Suzuki,et al. Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin , 2015, Science.
[30] M. Floch. The effect of probiotics on host metabolism: the microbiota and fermentation. , 2010, Journal of clinical gastroenterology.
[31] S. Wilhelm,et al. A review of infliximab use in ulcerative colitis. , 2008, Clinical therapeutics.
[32] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[33] N. Shepherd,et al. Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease , 2006, Alimentary pharmacology & therapeutics.